Loading…
Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study
Currently, it is unclear whether treating Helicobacter pylori ( H. pylori ) infection is safe among adolescents. This study aimed to evaluate the safety of H. pylori eradication therapy by examining gut microbiota changes in adolescents 3 months after the therapy. H. pylori -infected adolescents wer...
Saved in:
Published in: | Scientific reports 2021-01, Vol.11 (1), p.755-755, Article 755 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Currently, it is unclear whether treating
Helicobacter pylori
(
H. pylori
) infection is safe among adolescents. This study aimed to evaluate the safety of
H. pylori
eradication therapy by examining gut microbiota changes in adolescents 3 months after the therapy.
H. pylori
-infected adolescents were enrolled in this study. Their stool samples were collected at the following three time points: before treatment, 1–2 days after completion of treatment, and time of eradication successful judgment. We assessed the relative abundance, alpha-diversity, and beta-diversity of the gut microbiota and adverse events. The number of isolated
Actinobacteria
decreased immediately after eradication therapy in the 16 students included in the study, and it returned to pretreatment condition at the eradication judgment point. There was no change in the relative abundance at genus level. The alpha-diversity was lost immediately after eradication therapy; however, it recovered at the time of eradication judgment, and it was restored to pretreatment condition. Meanwhile, none of the participants experienced serious adverse events.
H. pylori
eradication therapy is safe for adolescents with respect to gut microbiota changes associated with
H. pylori
eradication therapy. Therefore, further long-term evaluations of gut microbiota changes following eradication therapy are warranted. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-020-80802-3 |